Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
09/1996
09/11/1996CN1130863A Composition containing phosphate derivatives
09/11/1996CN1130530A Cuochuangjing-external use medicine for treating acne
09/11/1996CN1130529A Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof
09/11/1996CN1130527A Xinshouling capsule for treating heart diseases
09/11/1996CN1130526A Medicinal powder for improving eyesight and preparing process thereof
09/11/1996CN1130525A Quick-acting ointment for removing dampness and relieving cancer
09/11/1996CN1130524A Shenmai (liquid, tablet and instant granule)
09/11/1996CN1130520A Fragrant health chewing gum
09/11/1996CN1130518A Jiuweimingmuzhujing powder for improving eyesight
09/11/1996CN1130516A Chinese patent drug for treating throat diseases and producing process
09/11/1996CN1130514A Refined full-scorpion injection and preparing process thereof
09/11/1996CN1130511A Medicine for treating foot sweat (bad smell)
09/11/1996CN1130509A Microcapsulated zinc gluconate and producing process thereof
09/11/1996CN1130506A Pharmaceutical formulations of cefaclor
09/11/1996CN1130474A 雾化口香糖 Atomization gum
09/10/1996US5554730 Vaccines
09/10/1996US5554650 Mixture of diclofenac or salt with water and surfactants; side effect reduction
09/10/1996US5554646 Method for reducing body fat in animals
09/10/1996US5554598 Method of treating crural or decubitus ulcer with zinc hyaluroric acid complex
09/10/1996US5554597 Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
09/10/1996US5554596 Polymer with lignin units and lignoid units
09/10/1996US5554388 Systemic drug delivery compositions comprising a polycationi substance
09/10/1996US5554387 Sustained release heterodisperse hydrogel systems for insoluble drugs
09/10/1996US5554385 High amylose starch substituted gelatin capsules
09/10/1996US5554384 High dose formulations of mycophenolate mofetil and mycophenolic acid
09/10/1996US5554382 Critical fluids
09/10/1996US5554381 Low flux matrix system for delivering potent drugs transdermally
09/10/1996US5554380 Bioadhesive pharmaceutical delivery system
09/10/1996US5554379 Long acting GI and esophageal protectant
09/10/1996US5554378 Pharmaceutical composition and its mucosal use
09/10/1996US5554367 Compositions for treatment of glaucoma
09/10/1996US5554187 For implantation into an eye
09/10/1996US5554150 Granulocyte colony-stimulating factor solution delivery method
09/10/1996US5554148 Renewable neural implant device and method
09/10/1996US5554147 Compositions and devices for controlled release of active ingredients
09/10/1996CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions
09/10/1996CA2009890C Valproic acid
09/10/1996CA1338589C Aqueous solution of triglyceride substrate for determination of lipase
09/08/1996CA2170687A1 Mixed micelles
09/06/1996WO1996026890A2 Method of producing hydrophilic or partially hydrophilic inorganic aerogels
09/06/1996WO1996026746A1 Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
09/06/1996WO1996026745A1 Biosynthetic virus vectors for gene therapy
09/06/1996WO1996026742A1 Gene transfer-mediated angiogenesis therapy
09/06/1996WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors
09/06/1996WO1996026726A1 Pharmaceutical composition for piperidinoalkanol compounds
09/06/1996WO1996026720A1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors
09/06/1996WO1996026719A1 A prolonged release composition, use and production thereof
09/06/1996WO1996026718A2 Controlled release tablet
09/06/1996WO1996026717A1 Sustained release formulation containing three different types of polymers
09/06/1996WO1996026716A1 Elcatonin controlled release microsphere formulation for treatment of osteoporosis
09/06/1996WO1996026715A1 Method for loading lipid vesicles
09/06/1996WO1996026714A1 Process for the preparation of a solid pharmaceutical dosage form
09/06/1996WO1996026710A1 Cosmetic and/or pharmaceutical preparations
09/06/1996WO1996026647A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996WO1996021470A3 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
09/06/1996WO1996020208A3 New cholesterol derivative for liposomal gene transfer
09/06/1996WO1996018372A3 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
09/06/1996CA2213971A1 Supplement for baby infant formula and a method of delivering that supplement
09/06/1996CA2213455A1 Controlled release tablet
09/06/1996CA2188575A1 Gene transfer-mediated angiogenesis therapy
09/05/1996DE19507203A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations
09/05/1996DE19504831A1 Feste Wirkstoffzubereitungen enthaltend Hydroxypropylcellulose Fixed drug preparations containing hydroxypropyl cellulose
09/04/1996EP0729781A1 Surfactant, and emulsion cosmetic and liposome each containing the same
09/04/1996EP0729756A1 Granular preparation
09/04/1996EP0729751A1 Controlled release formulation containing tramadol
09/04/1996EP0729749A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/04/1996EP0729748A1 Process for producing stable medicinal composition, and pharmaceutical preparation
09/04/1996EP0729747A1 Use of amphiphilic compounds as thickening agent of non aqueous media and composition obtained
09/04/1996EP0729745A1 Vitamin C delivery system
09/04/1996EP0729382A1 Alkylglycoside-containing concentrate and uses thereof
09/04/1996EP0729369A1 Method and apparatus for delivering oxygen into blood
09/04/1996EP0729362A1 TRANSDERMAL COMPOSITION OF N- N- 5- 4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-$g(a)-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
09/04/1996EP0729358A1 Transdermal prostaglandin composition
09/04/1996EP0729357A1 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
09/04/1996EP0729353A1 Preparation of biodegradable microparticles containing a biologically active agent
09/04/1996EP0729352A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
09/04/1996EP0729351A1 Vesicles with controlled release of actives
09/04/1996EP0729350A1 Hydrophobic preparations
09/04/1996EP0729343A1 Cold-water emulsifiable agents
09/04/1996EP0729324A1 Biocompatible ocular implants
09/04/1996CN1130352A Controlled-releasing opioid formulations for treating pain
09/04/1996CN1130351A Ophtalmic solution based on diclofenac and tobramicine and its application
09/04/1996CN1130087A Rana japonica oil oral liquor
09/04/1996CN1130086A Quick-action defatting liquid and its preparing method
09/04/1996CN1130085A Hyperthyroidism plaster and its preparing method
09/04/1996CN1130083A Oral administration liquid for curing acne and its preparing method
09/04/1996CN1130080A Shentai powder preparation for tonifying kidney and its production technique
09/04/1996CN1130079A Adhesive plaster for alleviating pain and detumescence
09/04/1996CN1130078A Zhuifengtougu plaster for dissipating wind and removing dampness
09/04/1996CN1130074A External application medicine for chronic rheumatic hyperosteogeny
09/04/1996CN1130067A Chum salmon white essence oral liquor and its production technique
09/04/1996CN1130064A Solid medicinal composition containing ecipient capable of combining water
09/04/1996CN1130061A Amino-phenol acetate, pseudoephedrine, chlorpheniramine maleate and with and without dextromethorphan rotary granulating and coating
09/04/1996CN1130060A Ketopheny/propionate plastid
09/04/1996CN1130026A Method for producing ganoderma spore nutritive powder
09/04/1996CN1032675C Concentrated water solution containing spiramycin depressor for intravenous injection after dilution
09/04/1996CA2170844A1 Pharmaceutical compositions containing dinoreburnamenine derivatives
09/03/1996US5552428 Antiarrhythmia agents for cardiovascular disorders using melatonin derivatives
09/03/1996US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
09/03/1996US5552378 Solid consumer product compositions containing small particle cyclodextrin complexes
1 ... 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 2697 2698 2699 2700 2701 2702 2703 2704 2705 2706 ... 2991